ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q1 2023?

57 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q1 2023. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Shares, par value CHF 0.08 per share
Total 13F shares: 46,611,135
Total 13F value: $90,890,151
Share change: +7,776,825
Put/Call ratio: 1686%
SEC-reported price per share: $1.95
Number of holders: 57
Value change: +$6,156,453
Number of buys: 37
Number of sells: 27
Shares outstanding: 127,205,201

Security key

H0036K147

Report period

Q1 2023

Institutions

Top holders

ADCT full security history Ownership snapshot Full 13F holder table ADC Therapeutics SA SEC filings ADC Therapeutics SA company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Redmile Group, LLC

Disclosed value leader

Redmile Group, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 6% Showing 1-6 of 15 holder rows.

Quick read

Redmile Group, LLC leads the comparable SEC ownership view at 6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Redmile Group, LLC's linked filing trail.

Comparable ownership Top 5

Redmile Group, LLC 6%

FMR LLC 3.7%

MILLENNIUM MANAGEMENT LLC 2.7%

JPMORGAN CHASE & CO 2.4%

ALLIANCEBERNSTEIN L.P. 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Redmile Group, LLC	13F Company 13F	6%	$29,148,860 7,590,849 shares	—	31 Dec 2022
FMR LLC	13F Company 13F	3.7%	$17,869,261 4,653,453 shares	—	31 Dec 2022
MILLENNIUM MANAGEMENT LLC	13F Company 13F	2.7%	$13,060,000 3,401,120 shares	—	31 Dec 2022
JPMORGAN CHASE & CO	13F Company 13F	2.4%	$11,538,000 3,004,466 shares	—	31 Dec 2022
ALLIANCEBERNSTEIN L.P.	13F Company 13F	2.2%	$10,847,831 2,824,956 shares	—	31 Dec 2022
GOLDMAN SACHS GROUP INC	13F Company 13F	1.7%	$8,299,607 2,161,356 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

46,611,135

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %